GSK
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of GSK generated cash of $6,768,000,000, which is less than the previous year. Cash used in financing activities reached the amount of -$5,641,000,000 last year. Net change in cash is therefore -$567,000,000.
Cash Flow
| 2014 | 5.17B | -1.07B | -5.38B |
|---|---|---|---|
| 2015 | 2.56B | 6.03B | -7.10B |
| 2016 | 6.49B | -1.26B | -6.39B |
| 2017 | 6.91B | -1.44B | -6.38B |
| 2018 | 8.42B | -1.55B | -6.38B |
| 2019 | 8.02B | -5.35B | -1.84B |
| 2020 | 8.44B | 2.16B | -10.13B |
| 2021 | 7.95B | -1.77B | -7.58B |
| 2022 | 7.40B | -8.77B | 823M |
| 2023 | 6.76B | -1.59B | -5.64B |
GSK Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 3.42B | 3.81B | 5.26B | 4.83B | 4.08B | 3.6B | 4.60B | 5.48B | 4.02B | 5.23B |
Operating activities | ||||||||||
Net income | 4.92B | 4.92B | 5.09B | 6.38B | 5.26B | 4.04B | 2.16B | 1.06B | 8.37B | 2.83B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.29B | 2.29B | 2.52B | 624M | 2.99B | 1.76B | 2.98B | 1.86B | 1.86B | 2.02B |
Stock-based compensation expense | 307M | 346M | 343M | 337M | 365M | 360M | 333M | 319M | 368M | 332M |
| Deferred income tax benefit | 307M | 346M | 343M | 337M | 365M | 360M | 333M | 319M | 368M | 332M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -649M | -616M | -1.16B | -383M | -192M | -411M | -213M | 193M | 98M | 347M |
Inventories | -424M | -269M | 25M | 119M | 300M | 51M | -461M | 70M | -111M | -529M |
Accounts payable | -15M | 494M | 229M | 225M | 263M | 131M | 11M | 96M | 0 | 0 |
Cash generated by operating activities | 6.76B | 7.40B | 7.95B | 8.44B | 8.02B | 8.42B | 6.91B | 6.49B | 2.56B | 5.17B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -144M | 1.75B | -1M | -258M | -309M | 4M | -928M | -2M | 1M |
Investments In Property Plant And Equipment | -1.31B | -2.25B | -2.93B | -2.23B | -2.16B | -1.79B | -2.20B | -2.35B | -1.90B | -1.75B |
Acquisitions Net | -1.46B | -3.13B | 185M | 3.00B | -3.78B | -292M | 356M | 592M | 7.52B | 235M |
Cash generated by investing activities | -1.59B | -8.77B | -1.77B | 2.16B | -5.35B | -1.55B | -1.44B | -1.26B | 6.03B | -1.07B |
Financing activities | ||||||||||
Common Stock Issued | 10M | 25M | 21M | 29M | 51M | 74M | 56M | 89M | 73M | 167M |
Payments for dividends | -2.24B | -3.46B | -3.99B | -3.97B | -3.95B | -3.92B | -3.90B | -4.85B | -3.87B | -3.84B |
Repurchases of common stock | 0 | 0 | -1.64B | 999M | 0 | 8.77B | -65M | -74M | -99M | -333M |
Repayments of term debt | -2.37B | -771M | -1.99B | -7.30B | 4.58B | -1.98B | -967M | -919M | -2.41B | -1.70B |
Cash used in financing activities | -5.64B | 823M | -7.58B | -10.13B | -1.84B | -6.38B | -6.38B | -6.39B | -7.10B | -5.38B |
Net Change In Cash | -567M | -394M | -1.44B | 431M | 744M | 487M | -1.00B | -881M | 1.45B | -1.20B |
Cash at end of period | 2.85B | 3.42B | 3.81B | 5.26B | 4.83B | 4.08B | 3.6B | 4.60B | 5.48B | 4.02B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |